Clinical Trial Update: Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain [Phase 3]

View source ↗

Summary

This document announces the completion of a Phase 3 extension study evaluating the safety of Q8003 in patients with acute moderate to severe pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• To Severe Pain

Drugs mentioned

• Q8003

Snippet

Sponsor: QRxPharma Inc. | Conditions: Acute Moderate to Severe Pain | Phase 3 | Status: COMPLETED